Vivek D Koppikar

Array ( [id] => 4249122 [patent_doc_number] => 06221868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives' [patent_app_type] => 1 [patent_app_number] => 9/446423 [patent_app_country] => US [patent_app_date] => 1999-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18277 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221868.pdf [firstpage_image] =>[orig_patent_app_number] => 446423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508003 [patent_doc_number] => 06441001 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => '2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity' [patent_app_type] => B1 [patent_app_number] => 09/465301 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37864 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 4569 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441001.pdf [firstpage_image] =>[orig_patent_app_number] => 09465301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323021 [patent_doc_number] => 06331541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity' [patent_app_type] => 1 [patent_app_number] => 9/465288 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73848 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6614 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331541.pdf [firstpage_image] =>[orig_patent_app_number] => 465288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249108 [patent_doc_number] => 06221867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => '4,5-pyrazinoxindoles' [patent_app_type] => 1 [patent_app_number] => 9/464534 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9348 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221867.pdf [firstpage_image] =>[orig_patent_app_number] => 464534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409748 [patent_doc_number] => 06265399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Certain benzothiazine dioxide endothelin antagonists and processes for their preparation' [patent_app_type] => 1 [patent_app_number] => 9/445504 [patent_app_country] => US [patent_app_date] => 1999-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20992 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265399.pdf [firstpage_image] =>[orig_patent_app_number] => 445504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409779 [patent_doc_number] => 06172228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Process for producing piperazinesulfonamide derivatives and salts thereof' [patent_app_type] => 1 [patent_app_number] => 9/453223 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28652 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 321 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172228.pdf [firstpage_image] =>[orig_patent_app_number] => 453223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4368314 [patent_doc_number] => 06274587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Tricyclic dihydropyrimidine potassium channel openers' [patent_app_type] => 1 [patent_app_number] => 9/443212 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18840 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274587.pdf [firstpage_image] =>[orig_patent_app_number] => 443212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4360693 [patent_doc_number] => 06175009 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Process for the preparation of quinazolinones' [patent_app_type] => 1 [patent_app_number] => 9/442598 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15075 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/175/06175009.pdf [firstpage_image] =>[orig_patent_app_number] => 442598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306865 [patent_doc_number] => 06187923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Process for the synthesis of quinazolinones' [patent_app_type] => 1 [patent_app_number] => 9/435517 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4982 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187923.pdf [firstpage_image] =>[orig_patent_app_number] => 435517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185800 [patent_doc_number] => 06159987 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Bicyclolactam compounds, use thereof and intermediates for preparing thereof' [patent_app_type] => 1 [patent_app_number] => 9/432115 [patent_app_country] => US [patent_app_date] => 1999-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23721 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159987.pdf [firstpage_image] =>[orig_patent_app_number] => 432115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291863 [patent_doc_number] => 06235730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => '3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same' [patent_app_type] => 1 [patent_app_number] => 9/367242 [patent_app_country] => US [patent_app_date] => 1999-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37874 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 533 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235730.pdf [firstpage_image] =>[orig_patent_app_number] => 367242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288475 [patent_doc_number] => 06211187 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => '3-aryl substituted pyrazolo[4,3-d]pyrimidine deriviatives; corticotropin-releasing factor receptor (CRF1) specific ligands' [patent_app_type] => 1 [patent_app_number] => 9/341024 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6202 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211187.pdf [firstpage_image] =>[orig_patent_app_number] => 341024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4337868 [patent_doc_number] => 06333330 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction' [patent_app_type] => 1 [patent_app_number] => 9/426554 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49118 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 482 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333330.pdf [firstpage_image] =>[orig_patent_app_number] => 426554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284496 [patent_doc_number] => 06268120 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Isoalloxazine derivatives to neutralize biological contaminants' [patent_app_type] => 1 [patent_app_number] => 9/420652 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9583 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268120.pdf [firstpage_image] =>[orig_patent_app_number] => 420652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523961 [patent_doc_number] => 06352982 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => '4,1-benzoxazepines, their analogues, and their use as somatostatin agonists' [patent_app_type] => B1 [patent_app_number] => 09/403066 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107479 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5023 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352982.pdf [firstpage_image] =>[orig_patent_app_number] => 09403066 [rel_patent_id] =>[rel_patent_doc_number] =>)